Details for New Drug Application (NDA): 210872
The generic ingredient in ZURAGARD is isopropyl alcohol. There is one drug master file entry for this compound. Additional details are available on the isopropyl alcohol profile page.
Summary for 210872
| Tradename: | ZURAGARD |
| Applicant: | Zurex Pharma |
| Ingredient: | isopropyl alcohol |
| Patents: | 5 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 210872
Generic Entry Date for 210872*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION;TOPICAL | Strength | 70% | ||||
| Approval Date: | Apr 26, 2019 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Dec 20, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY | ||||||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Aug 9, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY | ||||||||
| Patent: | ⤷ Start Trial | Patent Expiration: | May 23, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 210872
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | ⤷ Start Trial | ⤷ Start Trial |
| Zurex Pharma | ZURAGARD | isopropyl alcohol | SOLUTION;TOPICAL | 210872-001 | Apr 26, 2019 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
